GENEVA, Nov. 25 -- ADVENCHEN PHARMACEUTICALS, LLC (887 Patriot Drive, Ste AMoorpark, CA 93021) filed a patent application (PCT/US2025/029436) for "USING CATEQUENTINIB WITH A SPECIFIC ADMINISTRATION REGIMEN FOR CANCER TREATMENT" on May 14, 2025. With publication no. WO/2025/240663, the details related to the patent application was published on Nov 20, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): CHEN, Guoqing, Paul (887 Patriot Drive, STE AMoorpark, CA 93021), CHEN, Judy (887 Patriot Drive, STE AMoorpark, CA 93021), LI, Zhe (887 Patriot Drive, STE AMoorpark, CA 93021)
Abstract: The presen...